Stem cells might mend broken bones; Anti-cancer drug combos all the rage;

Stem Cells

> A stem cell treatment enriched with a bone-regenerating hormone, insulin-like growth factor (IGF-I), might help mend broken bones that do not heal. Release

> The New York Stem Cell Foundation awards fellowships to 7 innovative stem cell scientists. Winners listed here

> U.S. Sen. Mark Kirk, (R-IL) sides with legislation that backs stem cell research. Item

Cancer Research

> If one cancer drug is good, two or more is better. The use of drug combinations to treat cancer is expected to increase, and even move into earlier stages of development, as companies seek more potent treatments and better returns on their research investment, MarketWatch reports. Story

> Could anti-melanoma drugs actually promote metastasis and contribute to relapse? Research at Cold Spring Harbor Laboratory suggests this might be the case. Release

> A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. Article

Genetics

> A survey of European clinical geneticists has revealed opposition to direct-to-consumer genetic testing. Article

> Scientists have identified a set of 15 genes that are associated with triple-negative breast cancer, an aggressive form of the disease that does not respond to the drugs commonly used to treat other types of breast cancer. Story

> Both genetics and environment might trigger multiple sclerosis. Release

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.